Fount Bio’s Flī-Derm™ dermatology product demonstrates impressive aesthetic improvement in clinical study
The company will present results of its blinded study at the Dermatology Summit at JPM 2024 in San Francisco on January 7, 2024 CAMBRIDGE, MA December 11, 2023 – Life sciences innovator Fount Bio, Inc., today announced it has successfully completed its first clinical study demonstrating the safety and efficacy ...
Fount Bio announces Dan Browne, MBA to join Board of Directors.
Fount Bio, Inc. is pleased to announce the appointment of Dan Browne as an independent Director to Fount Bio’s Board of Directors. Dan joins current board members Anthony Aiudi and Justin Burns from Morningside Ventures and co-founders Samir Mitragotri and Douglas Levinson. Dan Browne has more than 30 years of ...
